OBJECTIVE: To study the efficacy and mechanism of local transdermal photodynamic therapy (tPDT) in rabbits with antigen-induced arthritis (AIA). METHODS: AIA in rabbits on day 14 postinduction was treated with an intravenous injection of benzoporphyrin-derivative monoacid ring A (BPD; Verteporfin) and subsequent transdermal exposure of the knee joint to light. BPD uptake and PDT-induced apoptosis of the synovium was studied applying fluorescence confocal microscopy and immunohistochemistry. The (histo)pathology of the joints was assessed at day 28. RESULTS: Treatment with tPDT resulted in significant amelioration of synovial inflammation and an almost complete prevention of pannus formation and bone and cartilage destruction. BPD uptake was detectable in activated T cells and macrophages, and there was significant PDT-induced increase in the number of apoptotic cells in the synovium. CONCLUSION: Because photodynamic therapy is both specific and noninvasive, our findings suggest that it could be used for treating arthritic joints in humans.
OBJECTIVE: To study the efficacy and mechanism of local transdermal photodynamic therapy (tPDT) in rabbits with antigen-induced arthritis (AIA). METHODS: AIA in rabbits on day 14 postinduction was treated with an intravenous injection of benzoporphyrin-derivative monoacid ring A (BPD; Verteporfin) and subsequent transdermal exposure of the knee joint to light. BPD uptake and PDT-induced apoptosis of the synovium was studied applying fluorescence confocal microscopy and immunohistochemistry. The (histo)pathology of the joints was assessed at day 28. RESULTS: Treatment with tPDT resulted in significant amelioration of synovial inflammation and an almost complete prevention of pannus formation and bone and cartilage destruction. BPD uptake was detectable in activated T cells and macrophages, and there was significant PDT-induced increase in the number of apoptotic cells in the synovium. CONCLUSION: Because photodynamic therapy is both specific and noninvasive, our findings suggest that it could be used for treating arthritic joints in humans.
Authors: Angel Bottini; Dennis J Wu; Rizi Ai; Michelle Le Roux; Beatrix Bartok; Michele Bombardieri; Karen M Doody; Vida Zhang; Cristiano Sacchetti; Martina Zoccheddu; Ana Lonic; Xiaochun Li; David L Boyle; Deepa Hammaker; Tzu-Ching Meng; Lin Liu; Maripat Corr; Stephanie M Stanford; Myles Lewis; Wei Wang; Gary S Firestein; Yeesim Khew-Goodall; Costantino Pitzalis; Nunzio Bottini Journal: Ann Rheum Dis Date: 2019-02-26 Impact factor: 19.103
Authors: Sriram Anbil; Imran Rizvi; Jonathan P Celli; Nermina Alagic; Brian W Pogue; Tayyaba Hasan Journal: J Biomed Opt Date: 2013-09 Impact factor: 3.170
Authors: S Miyazawa; K Nishida; T Komiyama; Y Nakae; K Takeda; M Yorimitsu; A Kitamura; T Kunisada; A Ohtsuka; H Inoue Journal: Rheumatol Int Date: 2005-10-12 Impact factor: 2.631
Authors: Rebecca A Symons; Fabio Colella; Anke J Roelofs; Cosimo De Bari; Fraser L Collins; Alexandra J Rafipay; Karolina Kania; Jessica J McClure; Nathan White; Iain Cunningham; Sadaf Ashraf; Elizabeth Hay; Kevin S Mackenzie; Kenneth A Howard; Anna H K Riemen; Antonio Manzo; Susan M Clark Journal: Ann Rheum Dis Date: 2021-11-29 Impact factor: 19.103